Compile Data Set for Download or QSAR
Report error Found 133 for UniProtKB: Q14498
TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659427(US20240092770, Compound 2)
Affinity DataEC50:  1.03E+3nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659428(US20240092770, Compound 3)
Affinity DataEC50:  429nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659429(US20240092770, Compound 7)
Affinity DataEC50:  106nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659430(US20240092770, Compound 8)
Affinity DataEC50:  787nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659431(US20240092770, Compound 9)
Affinity DataEC50:  436nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659432(US20240092770, Compound 10)
Affinity DataEC50:  75.7nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659433(US20240092770, Compound 11)
Affinity DataEC50:  108nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659434(US20240092770, Compound 12)
Affinity DataEC50:  384nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659435(US20240092770, Compound 13)
Affinity DataEC50:  298nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659436(US20240092770, Compound 24)
Affinity DataEC50:  269nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659437(US20240092770, Compound 25)
Affinity DataEC50:  1.09E+3nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659438(US20240092770, Compound 27)
Affinity DataEC50:  2.80E+3nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659439(US20240092770, Compound 32)
Affinity DataEC50:  136nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659440(US20240092770, Compound 34)
Affinity DataEC50:  301nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659441(US20240092770, Compound 36)
Affinity DataEC50:  354nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659442(US20240092770, Compound 37)
Affinity DataEC50:  427nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659443(US20240092770, Compound 38)
Affinity DataEC50:  4.19E+3nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659444(US20240092770, Compound 39)
Affinity DataEC50:  520nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659445(US20240092770, Compound 40)
Affinity DataEC50:  275nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659446(US20240092770, Compound 41)
Affinity DataEC50:  363nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659447(US20240092770, Compound 42)
Affinity DataEC50:  55.2nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659448(US20240092770, Compound 43)
Affinity DataEC50: >3.00E+4nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659449(US20240092770, Compound 44)
Affinity DataEC50:  904nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659450(US20240092770, Compound 45)
Affinity DataEC50:  394nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659451(US20240092770, Compound 47)
Affinity DataEC50:  97nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659452(US20240092770, Compound 48)
Affinity DataEC50:  125nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659453(US20240092770, Compound 49)
Affinity DataEC50:  190nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659454(US20240092770, Compound 50)
Affinity DataEC50:  966nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659455(US20240092770, Compound 51)
Affinity DataEC50:  164nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659456(US20240092770, Compound 55)
Affinity DataEC50:  302nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659457(US20240092770, Compound 57)
Affinity DataEC50: >3.00E+4nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659458(US20240092770, Compound 58)
Affinity DataEC50:  1.08E+3nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659459(US20240092770, Compound 59)
Affinity DataEC50:  802nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659460(US20240092770, Compound 60)
Affinity DataEC50:  1.36E+3nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659461(US20240092770, Compound 61)
Affinity DataEC50:  1.79E+3nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659462(US20240092770, Compound 63)
Affinity DataEC50:  1.17E+3nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659463(US20240092770, Compound 64)
Affinity DataEC50:  3.44E+3nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659464(US20240092770, Compound 65)
Affinity DataEC50:  1.08E+3nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659465(US20240092770, Compound 67)
Affinity DataEC50:  520nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659466(US20240092770, Compound 68)
Affinity DataEC50:  708nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659467(US20240092770, Compound 69)
Affinity DataEC50:  421nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659468(US20240092770, Compound 70)
Affinity DataEC50:  338nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659469(US20240092770, Compound 71)
Affinity DataEC50:  532nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659470(US20240092770, Compound 72)
Affinity DataEC50:  432nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659471(US20240092770, Compound 73 | US20240092770, Compou...)
Affinity DataEC50:  738nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659472(US20240092770, Compound 74)
Affinity DataEC50:  1.45E+3nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659473(US20240092770, Compound 75)
Affinity DataEC50:  2.18E+3nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659474(US20240092770, Compound 76)
Affinity DataEC50:  3.32E+3nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659475(US20240092770, Compound 77)
Affinity DataEC50:  828nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

TargetRNA-binding protein 39 [150-331]/DDB1- and CUL4-associated factor 15(Human)
Recursion Pharmaceuticals

US Patent
LigandPNGBDBM659476(US20240092770, Compound 78)
Affinity DataEC50:  3.25E+3nMAssay Description:A TR-FRET assay was used to assess the effect of compounds disclosed herein on the interaction between RBM39 and the DCAF15 complex. Test compounds w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2024
Entry Details
Go to US Patent

Displayed 1 to 50 (of 133 total ) | Next | Last >>
Jump to: